Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study
- Vipul Jairath
- , Geert D'Haens
- , Bruce E. Sands
- , Simon Travis
- , María Chaparro
- , Laurent Peyrin-Biroulet
- , Min hu Chen
- , Marla Dubinsky
- , Marc Ferrante
- , Stefan Schreiber
- , Kim McGinnis
- , Aisha Vadhariya
- , Saskia Appelmans
- , Zhantao Lin
- , Guanglei Yu
- , Marijana Protic
- , Richard Moses
- , Subrata Ghosh
- London Health Sciences Centre
- Western University
- Amsterdam University Medical Centers
- Icahn School of Medicine at Mount Sinai
- University of Oxford
- Hospital Universitario de la Princesa
- Institut national de la santé et de la recherche médicale
- Groupe Hospitalier Privé Ambroise Paré - Hartmann
- McGill University
- The First Affiliated Hospital of Sun Yat-Sen University
- KU Leuven
- University Hospital Schleswig-Holstein
- Eli Lilly
Research output: Contribution to journal › Article › peer-review